Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

67%

4 of 6 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 2

7(87.5%)

Phase 1

1(12.5%)

8Total

Phase 2(7)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05965726Phase 2Completed

RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms

Role: lead

NCT06305780Phase 2Completed

RECOVER-AUTONOMIC Platform Protocol

Role: lead

NCT06305806Phase 2Completed

RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)

Role: lead

NCT04973345Phase 2Withdrawn

Terbutaline Sulfate in Adults With Asthma

Role: lead

NCT05595369Phase 2Completed

RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

Role: lead

NCT06305793Phase 2Active Not Recruiting

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

Role: lead

NCT05425420Phase 1Completed

Single Dose IV Methadone for Post-Op Pain

Role: lead

NCT02913612Phase 2Completed

Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)

Role: lead

All 8 trials loaded